NCT07156825 Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
| NCT ID | NCT07156825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Semmelweis University |
| Condition | Hearing Loss |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-08-05 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects. The present paper provides a protocol and an example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language.
Eligibility Criteria
Inclusion Criteria: * Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively. * For control goups: normal hearing verified by pure tone audiometry and tympanometry * For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics Exclusion Criteria: * Children presenting with symptoms of upper respiratory tract infections * Known speech-language developmental disorders * Cognitive disorders
Contact & Investigator
Anita Gaborjan, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Semmelweis University
Frequently Asked Questions
Who can join the NCT07156825 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 7 Years, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07156825 currently recruiting?
Yes, NCT07156825 is actively recruiting participants. Contact the research team at vasvari.gergely.pal@semmelweis.hu for enrollment information.
Where is the NCT07156825 trial being conducted?
This trial is being conducted at Budapest, Hungary.
Who is sponsoring the NCT07156825 clinical trial?
NCT07156825 is sponsored by Semmelweis University. The principal investigator is Anita Gaborjan, M.D., Ph.D. at Semmelweis University. The trial plans to enroll 120 participants.